Gregory J. Mossinghoff
Gründer bei Tavros Therapeutics, Inc.
Profil
Gregory J.
Mossinghoff was the founder of Integrated Oncology Solutions, Inc. (founded in 2006) and Novolipid, Inc. (founded in 2010) where he held the titles of President & Chief Executive Officer.
He is also the founder of Tavros Therapeutics, Inc. Mr. Mossinghoff's former jobs include President, Chief Business Officer & Director at Inspire Pharmaceuticals, Inc. (1998-2005), Executive Vice President & Chief Business Officer at Zoion Pharma, Inc. (2010-2015), and Secretary & Chief Business Officer at G1 Therapeutics, Inc. (2015-2018).
Mr. Mossinghoff received his undergraduate degree from the University of Virginia and his MBA from George Mason University.
Aktive Positionen von Gregory J. Mossinghoff
| Unternehmen | Position | Beginn |
|---|---|---|
Tavros Therapeutics, Inc.
 Tavros Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tavros Therapeutics, Inc. operates as a biotechnology company. It develops novel therapies for cancer. The company was founded in 2019 and is headquartered in Durham, NC. | Gründer | - |
Ehemalige bekannte Positionen von Gregory J. Mossinghoff
| Unternehmen | Position | Ende |
|---|---|---|
| G1 THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2018 |
Zoion Pharma, Inc.
 Zoion Pharma, Inc. Pharmaceuticals: MajorHealth Technology Zoion Pharma, Inc. develops drugs for veterinary disorders. The private company is based in Stamford. | Corporate Officer/Principal | 01.01.2015 |
Novolipid, Inc.
 Novolipid, Inc. Pharmaceuticals: MajorHealth Technology Novolipid, Inc. develops oncology drug products. The private company is based in Durham. The American company was founded by Gregory J. Mossinghoff. | Vorstandsvorsitzender | 01.01.2013 |
| Integrated Oncology Solutions, Inc. | Vorstandsvorsitzender | 01.01.2010 |
Inspire Pharmaceuticals, Inc.
 Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | Präsident | 01.01.2005 |
Ausbildung von Gregory J. Mossinghoff
| University of Virginia | Undergraduate Degree |
| George Mason University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| G1 THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inspire Pharmaceuticals, Inc. operated as a biopharmaceutical company. It discovered and developed pharmaceutical products to treat diseases that results from deficiencies in the body's natural mechanisms of mucosal hydration. The company was founded by Kendall Harden, Richard C. Boucher, Andre L. Lamotte, H. Jefferson Leighton and Terrance G. McGuire and was headquartered in Whitehouse Station, NJ. | Health Technology |
| Integrated Oncology Solutions, Inc. | |
Zoion Pharma, Inc.
Zoion Pharma, Inc. Pharmaceuticals: MajorHealth Technology Zoion Pharma, Inc. develops drugs for veterinary disorders. The private company is based in Stamford. | Health Technology |
Novolipid, Inc.
Novolipid, Inc. Pharmaceuticals: MajorHealth Technology Novolipid, Inc. develops oncology drug products. The private company is based in Durham. The American company was founded by Gregory J. Mossinghoff. | Health Technology |
Tavros Therapeutics, Inc.
Tavros Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tavros Therapeutics, Inc. operates as a biotechnology company. It develops novel therapies for cancer. The company was founded in 2019 and is headquartered in Durham, NC. | Commercial Services |
